In addition, chromosomal rearrangements between 3q21 and 3q26 elicit high-risk acute myeloid leukemia, via the GATA2 enhancer reposition near the MECOM locus, which results in both EVI1 overexpression and GATA2 haploinsufficiency [38,39]. Here, MECOM is linked to acute myeloid leukemia.